Endocrine Therapy Drugs (ETDs) Market, By Drug Type, By Application, By Distribution Channel, By Geography

Description

Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at USD 35,300 Mn in 2026 and is expected to reach USD 50,000 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.1 % from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 35,300 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.10%	2033 Value Projection:	USD 50,000 Mn

The endocrine system of the human body uses hormones to control and coordinate with the human body's metabolism, reproduction, energy level, growth and development, as well as response for stress, injury, and mood disorders. Endocrine therapy, also known as hormone therapy, adds, blocks, or removes hormones/chemicals in order to treat diseases such as breast cancer, diabetes, etc. Estrogen and progesterone found in a woman's body can aggravate breast cancer as these hormones help the cells grow and spread throughout the body. Two types of endocrine therapy can be used for the treatment of breast cancer: blocking the action of estrogen and progesterone to stop them from helping cancerous cells to grow and, ablation or surgery to stop the ovary from producing estrogen and progesterone. Some of the endocrine therapy drugs used in breast cancer treatment include Abemaciclib (Verzenio), Anastrozole (Arimidex), Exemestane (Aromasin), and Fulvestrant (Faslodex), among others

Market Dynamics

The increasing prevalence of chronic diseases such as diabetes, breast cancer, and others, rising research and development activities to develop novel endocrine therapy drugs (ETDs), and increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global endocrine therapy drugs (ETDs) market over the forecast period.

For instance, according to the International Federation of Diabetes Atlas 2019, around 463 million people aged 20-79 years and 136 million people aged 65 are estimated to be suffering from diabetes in 2019, globally. Moreover, according to the International Diabetes Federation Diabetes Atlas 2019, the prevalence of diabetes in Costa Rica is predicted to increase form 9.1 in 2019 to 10.3 by 2030.

Key features of the study

This report provides an in-depth analysis of the global endocrine therapy drugs (ETDs) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global endocrine therapy drugs (ETDs) market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Novo Nordisk A/S, AstraZeneca, Generex Biotechnology, Orion Pharma AB, Sanofi, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co.,Inc., Bayer AG, Eli Lilly and Company, Abbott, Tonghua Dongbao Pharmaceutical Co., Ltd., Merck & Co., Inc., TherapeuticsMD, Inc., Pfizer Inc., Allergan, BioSante Pharmaceuticals, Amgen Inc., Noven Pharmaceuticals, Inc., and QuatRx Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global endocrine therapy drugs (ETDs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine therapy drugs (ETDs) market

Market Segmentation

By Drug Type
- Anti-diabetic Drugs
- Anti-osteoporosis Drugs
- Contraceptive Drugs
- Breast Cancer Drugs
- Others (Menopause Drugs, among others)
By Application
- Diabetes
- Breast Cancer
- Osteoporosis
- Menopause
- Contraception
- Others (Gender Reassignment Surgery, Hypothyroidism, among others)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players
- Novo Nordisk A/S
- AstraZeneca
- Generex Biotechnology
- Orion Pharma AB
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Hoffmann-La Roche
- Hisamitsu Pharmaceutical Co.,Inc.
- Bayer AG
- Eli Lilly and Company
- Abbott
- Tonghua Dongbao Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- TherapeuticsMD, Inc.
- Pfizer Inc.
- Allergan
- BioSante Pharmaceuticals
- Amgen Inc.
- Noven Pharmaceuticals, Inc.
- QuatRx Pharmaceuticals

Product Code: CMI5193

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Reimbursement Scenario
Mergers & Acquisitions
Epidemiology

4. Global Endocrine Therapy Drugs (ETDs) Market, By Drug Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Anti-diabetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Anti-osteoporosis Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Contraceptive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Breast Cancer Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others (Menopause Drugs, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Endocrine Therapy Drugs (ETDs) Market, By Application, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Contraception
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others (Gender Reassignment Surgery, Hypothyroidism, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Endocrine Therapy Drugs (ETDs) Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Endocrine Therapy Drugs (ETDs) Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
North America
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Novo Nordisk A/S
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Generex Biotechnology
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Orion Pharma AB
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sanofi
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- F. Hoffmann-La Roche
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Hisamitsu Pharmaceutical Co.,Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Tonghua Dongbao Pharmaceutical Co., Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- TherapeuticsMD, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Allergan
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BioSante Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amgen Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Noven Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- QuatRx Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact